{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:44:21Z","timestamp":1790315061626,"version":"4.1.0"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"vor","delay-in-days":343,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T00:00:00Z","timestamp":1580342400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T00:00:00Z","timestamp":1580342400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100001755","name":"Mesothelioma UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001755","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Mesothelioma UK"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,3,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Peritoneal mesothelioma (PM) is a rare primary neoplasm of the peritoneum with an increasing incidence worldwide. Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) has shown promise as a treatment strategy. A national PM multidisciplinary team (national PM MDT) video-conference meeting was established in the UK and Ireland in March 2016, aiming to plan optimal treatment, record outcomes and provide evidence for the benefits of centralization. This article reports on the activities and outcomes of the first 2\u00b75 years.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Between March 2016 and December 2018, patients with PM, referred to peritoneal malignancy centres in Basingstoke, Birmingham, Manchester and Dublin, were discussed by the national PM MDT via video-conference. The MDT was composed of surgeons, radiologists, specialist nurses and pathologists. Patients were considered for CRS and HIPEC if considered fit for surgery and if radiological imaging suggested that complete surgical cytoreduction could be achieved. Morbidity and mortality following surgery were analysed. Survival analysis following MDT discussion was conducted.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 155 patients (M : F ratio 0\u00b796) with a mean(s.d.) age of 57(17) years were discussed. To date, 22 (14\u00b72 per cent) have had CRS and HIPEC; the median Peritoneal Cancer Index for the surgical group was 17\u00b70. Complete cytoreduction was achieved in 19 patients. Clavien\u2013Dindo grade I\u2013II complications occurred in 16 patients; there was no grade III\u2013IV morbidity or 30-day in-hospital mortality. The median follow-up for the whole cohort was 18\u00b77 months, and the 2-year survival rate from time of first review at the national PM MDT was 68\u00b73 per cent.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The centralized national PM MDT was effective at selecting patients suitable for CRS and HIPEC, reporting a good outcome from patient selection.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1002\/bjs5.50256","type":"journal-article","created":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T07:49:20Z","timestamp":1580456960000},"page":"260-267","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Clinical and surgical outcomes of patients with peritoneal mesothelioma discussed at a monthly national multidisciplinary team video-conference meeting"],"prefix":"10.1093","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1990-2584","authenticated-orcid":false,"given":"A","family":"Brandl","sequence":"first","affiliation":[{"name":"Peritoneal Malignancy Institute, Basingstoke and North Hampshire Hospital , Basingstoke, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Westbrook","sequence":"additional","affiliation":[{"name":"Peritoneal Malignancy Institute, Basingstoke and North Hampshire Hospital , Basingstoke, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Nunn","sequence":"additional","affiliation":[{"name":"Peritoneal Malignancy Institute, Basingstoke and North Hampshire Hospital , Basingstoke, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Arbuthnot-Smith","sequence":"additional","affiliation":[{"name":"Peritoneal Malignancy Institute, Basingstoke and North Hampshire Hospital , Basingstoke, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Mulsow","sequence":"additional","affiliation":[{"name":"National Centre for Peritoneal Malignancy, Mater Misericordiae University Hospital , Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Youssef","sequence":"additional","affiliation":[{"name":"Good Hope Hospital, Heart of England NHS Foundation Trust , Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Carr","sequence":"additional","affiliation":[{"name":"Peritoneal Malignancy Institute, Basingstoke and North Hampshire Hospital , Basingstoke, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0128-0350","authenticated-orcid":false,"given":"A","family":"Tzivanakis","sequence":"additional","affiliation":[{"name":"Peritoneal Malignancy Institute, Basingstoke and North Hampshire Hospital , Basingstoke, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Dayal","sequence":"additional","affiliation":[{"name":"Peritoneal Malignancy Institute, Basingstoke and North Hampshire Hospital , Basingstoke, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Mohamed","sequence":"additional","affiliation":[{"name":"Peritoneal Malignancy Institute, Basingstoke and North Hampshire Hospital , Basingstoke, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B J","family":"Moran","sequence":"additional","affiliation":[{"name":"Peritoneal Malignancy Institute, Basingstoke and North Hampshire Hospital , Basingstoke, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Cecil","sequence":"additional","affiliation":[{"name":"Peritoneal Malignancy Institute, Basingstoke and North Hampshire Hospital , Basingstoke, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,1,30]]},"reference":[{"key":"2023020205310524100_bjs550256-bib-0001","volume-title":"Cytoreduction Surgery & Perioperative Chemotherapy for Peritoneal Surface Malignancy: Textbook and Video Atlas","author":"Sugarbaker","year":"2012"},{"key":"2023020205310524100_bjs550256-bib-0002","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/annonc\/mdl345","article-title":"Epidemiology of peritoneal mesothelioma: a review","volume":"18","author":"Boffetta","year":"2007","journal-title":"Ann Oncol"},{"key":"2023020205310524100_bjs550256-bib-0003","first-page":"79","article-title":"Diagnosis and management of patients with malignant peritoneal mesothelioma","volume":"7","author":"Alexander","year":"2016","journal-title":"J Gastrointest Oncol"},{"key":"2023020205310524100_bjs550256-bib-0004","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.5858\/133.8.1317","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group","volume":"133","author":"Husain","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"2023020205310524100_bjs550256-bib-0005","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.5858\/2006-130-1654-PSOHPI","article-title":"Prognostic significance of histomorphologic parameters in diffuse malignant peritoneal mesothelioma","volume":"130","author":"Cerruto","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"2023020205310524100_bjs550256-bib-0006","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/jso.21787","article-title":"Diffuse malignant peritoneal mesothelioma: systematic review of clinical management and biological research","volume":"103","author":"Baratti","year":"2011","journal-title":"J Surg Oncol"},{"key":"2023020205310524100_bjs550256-bib-0007","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.ejso.2016.03.017","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1000 patients with perforated appendiceal epithelial tumours","volume":"42","author":"Ansari","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"2023020205310524100_bjs550256-bib-0008","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1002\/cncr.25640","article-title":"Peritoneal Surface Oncology Group. A novel tumor-node-metastasis (TNM) staging system of diffuse malignant peritoneal mesothelioma using outcome analysis of a multi-institutional database*","volume":"117","author":"Yan","year":"2011","journal-title":"Cancer"},{"key":"2023020205310524100_bjs550256-bib-0009","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1245\/s10434-014-3978-x","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: a systematic review and meta-analysis","volume":"22","author":"Helm","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"2023020205310524100_bjs550256-bib-0010","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.surg.2013.01.001","article-title":"Treatment factors associated with long-term survival after cytoreductive surgery and regional chemotherapy for patients with malignant peritoneal mesothelioma","volume":"153","author":"Alexander","year":"2013","journal-title":"Surgery"},{"key":"2023020205310524100_bjs550256-bib-0011","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1016\/j.ejca.2013.05.027","article-title":"Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"49","author":"Baratti","year":"2013","journal-title":"Eur J Cancer"},{"key":"2023020205310524100_bjs550256-bib-0012","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","article-title":"Peritonectomy procedures","volume":"221","author":"Sugarbaker","year":"1995","journal-title":"Ann Surg"},{"key":"2023020205310524100_bjs550256-bib-0013","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1245\/s10434-015-4962-9","article-title":"The role of Ki-67 and pre-cytoreduction parameters in selecting diffuse malignant peritoneal mesothelioma (DMPM) patients for cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"23","author":"Kusamura","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"2023020205310524100_bjs550256-bib-0014","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1080\/02656736.2018.1434902","article-title":"Outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma and predictors of survival","volume":"34","author":"Gilani","year":"2018","journal-title":"Int J Hyperthermia"},{"key":"2023020205310524100_bjs550256-bib-0015","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"2023020205310524100_bjs550256-bib-0016","first-page":"111","article-title":"Low grade mesothelial tumors of the peritoneum: multicystic mesothelioma, well-differentiated papillary mesothelioma, and adenomatoid tumor","volume":"24","author":"Carr","year":"2019","journal-title":"AJSP Rev Rep"},{"key":"2023020205310524100_bjs550256-bib-0017","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/bmj.2.3317.147","article-title":"Fibrosis of the lungs due to the inhalation of asbestos dust","volume":"2","author":"Cooke","year":"1924","journal-title":"Br Med J"},{"key":"2023020205310524100_bjs550256-bib-0018","volume-title":"Mesothelioma: Distribution of Cases Diagnosed by Anatomic Site","author":"Cancer Research UK"},{"key":"2023020205310524100_bjs550256-bib-0019","author":"Royal College of Physicians","year":"2018","journal-title":"National Mesothelioma Audit Report 2018 (Audit Period 2014\u201316)"},{"key":"2023020205310524100_bjs550256-bib-0020","volume-title":"Cancer in Ireland 1994\u20132015 with Estimates for 2015\u20132017: Annual Report of the National Cancer Registry","author":"National Cancer Registry","year":"2017"},{"key":"2023020205310524100_bjs550256-bib-0021","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.crad.2017.07.005","article-title":"\u2018PAUSE\u2019: a method for communicating radiological extent of peritoneal malignancy","volume":"72","author":"Chandramohan","year":"2017","journal-title":"Clin Radiol"},{"key":"2023020205310524100_bjs550256-bib-0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40644-018-0187-z","article-title":"Whole-body diffusion-weighted MRI for operability assessment in patients with colorectal cancer and peritoneal metastases","volume":"19","author":"Dresen","year":"2019","journal-title":"Cancer Imaging"},{"key":"2023020205310524100_bjs550256-bib-0023","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1200\/JCO.2009.23.9640","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience","volume":"27","author":"Yan","year":"2009","journal-title":"J Clin Oncol"},{"key":"2023020205310524100_bjs550256-bib-0024","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3816\/CLC.2005.n.020","article-title":"Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma: outcomes of an expanded access program","volume":"7","author":"J\u00e4nne","year":"2005","journal-title":"Clin Lung Cancer"},{"key":"2023020205310524100_bjs550256-bib-0025","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1245\/s10434-018-6499-1","article-title":"Malignant peritoneal mesothelioma: national practice patterns, outcomes, and predictors of survival","volume":"25","author":"Verma","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"2023020205310524100_bjs550256-bib-0026","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.canep.2017.10.008","article-title":"Epidemiology of malignant peritoneal mesothelioma: a population-based study","volume":"51","author":"Salo","year":"2017","journal-title":"Cancer Epidemiol"},{"key":"2023020205310524100_bjs550256-bib-0027","doi-asserted-by":"crossref","first-page":"e368","DOI":"10.1016\/S1470-2045(19)30318-3","article-title":"Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications","volume":"20","author":"Alyami","year":"2019","journal-title":"Lancet Oncol"},{"key":"2023020205310524100_bjs550256-bib-0028","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1186\/s12885-018-4363-0","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for the treatment of malignant mesothelioma","volume":"18","author":"Giger-Pabst","year":"2018","journal-title":"BMC Cancer"}],"container-title":["BJS Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fbjs5.50256","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/bjs5.50256","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/bjs5.50256","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/bjsopen\/article-pdf\/4\/2\/260\/49040106\/bjs550256.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjsopen\/article-pdf\/4\/2\/260\/49040106\/bjs550256.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T05:33:59Z","timestamp":1675316039000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjsopen\/article\/4\/2\/260\/6061334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,30]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,3,24]]}},"URL":"https:\/\/doi.org\/10.1002\/bjs5.50256","relation":{},"ISSN":["2474-9842"],"issn-type":[{"value":"2474-9842","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,4]]},"published":{"date-parts":[[2020,1,30]]},"assertion":[{"value":"2019-08-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-29","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-30","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}